Technical Analysis for AMPE - Ampio Pharmaceutical

Grade Last Price % Change Price Change
D 0.2546 15.73% 0.0346
AMPE closed down 26.67 percent on Friday, March 17, 2023, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 15.73%
Fell Below 50 DMA Bearish 15.73%
MACD Bearish Centerline Cross Bearish 15.73%
MACD Bearish Signal Line Cross Bearish 15.73%
New Downtrend Bearish 15.73%
180 Bearish Setup Bearish Swing Setup 15.73%
Expansion Breakdown Bearish Swing Setup 15.73%
Expansion Pivot Sell Setup Bearish Swing Setup 15.73%
Wide Range Bar Range Expansion 15.73%
Wide Bands Range Expansion 15.73%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Gap Up Partially Closed 2 minutes ago
Rose Above Lower Bollinger Band about 1 hour ago
Gapped Up (Partial) about 1 hour ago
Up 5% about 1 hour ago
Up 3% about 1 hour ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Biopharmaceutical Pain Drug Discovery Arthritis Osteoarthritis Therapy Clinical Trial Covid 19 Treatment Of Osteoarthritis Ampion Ap 013 Ap 018 Ap 019

Is AMPE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.66
52 Week Low 0.016
Average Volume 119,039
200-Day Moving Average 0.0000
50-Day Moving Average 0.2886
20-Day Moving Average 0.2893
10-Day Moving Average 0.2881
Average True Range 0.0372
RSI 31.03
ADX 26.19
+DI 18.3272
-DI 20.1966
Chandelier Exit (Long, 3 ATRs) 0.2858
Chandelier Exit (Short, 3 ATRs) 0.3316
Upper Bollinger Bands 0.3451
Lower Bollinger Band 0.2335
Percent B (%b) -0.12
BandWidth 38.5759
MACD Line -0.0028
MACD Signal Line 0.0008
MACD Histogram -0.0036
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.3400
Resistance 3 (R3) 0.3533 0.3267 0.3200
Resistance 2 (R2) 0.3267 0.2961 0.3200 0.3133
Resistance 1 (R1) 0.2733 0.2772 0.2600 0.2600 0.3067
Pivot Point 0.2467 0.2467 0.2400 0.2400 0.2467
Support 1 (S1) 0.1933 0.2161 0.1800 0.1800 0.1333
Support 2 (S2) 0.1667 0.1972 0.1600 0.1267
Support 3 (S3) 0.1133 0.1667 0.1200
Support 4 (S4) 0.1000